Clinical Trial Update: Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines

View source ↗

Summary

Post-marketing surveillance trial of GSK's pneumococcal vaccine in healthy infants in the Philippines has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcal Infections

Drugs mentioned

• Synflorix (10-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Status: TERMINATED